Callum Chapman

Callum Chapman Head of Product Quality at AstraZeneca where he focuses on patient-centric quality in CMC development across multiple clinical and commercial products. He is a UK-registered pharmacist and quality professional with experience ensuring that quality frameworks align with clinical and manufacturing needs, particularly where CMC meets clinical development. Callum also frequently contributes to industry discussions on defining and controlling critical quality attributes for biologics and more recently, cell therapies.